Hyloris Pharmaceuticals SA (52U) Financial Statements
Hyloris Pharmaceuticals SA Financial Overview
Hyloris Pharmaceuticals SA's market cap is currently $107.24M. The company's EPS TTM is $-0.22; its P/E ratio is -23.64; Hyloris Pharmaceuticals SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.21M | $ 10.04M | $ 2.09M | $ 2.95M | $ 3.10M |
| Gross Profit | $ 5.91M | $ 9.81M | $ 1.99M | $ 2.86M | $ 2.99M |
| Operating Income | $ -9.34M | $ -7.13M | $ -15.99M | $ -11.64M | $ -4.94M |
| EBITDA | $ -8.62M | $ -4.85M | $ -14.98M | $ -11.43M | $ -10.78M |
| Net Income | $ -6.33M | $ -6.34M | $ -15.38M | $ -11.91M | $ -11.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.78M | $ 24.15M | $ 30.41M | $ 43.46M | $ 50.54M |
| Total Assets | $ 33.36M | $ 41.34M | $ 47.68M | $ 61.86M | $ 63.44M |
| Total Debt | $ 1.70M | $ 1.81M | $ 1.75M | $ 885.00K | $ 12.29M |
| Net Debt | $ -12.08M | $ -21.78M | $ -28.66M | $ -42.57M | $ -37.72M |
| Total Liabilities | $ 6.88M | $ 9.19M | $ 8.61M | $ 6.82M | $ 15.39M |
| Stockholders' Equity | $ 26.48M | $ 32.14M | $ 39.07M | $ 53.91M | $ 48.06M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.60M | $ -6.73M | $ -13.11M | $ -13.89M | $ -12.31M |
| Operating Cash Flow | $ -6.59M | $ -6.70M | $ -12.81M | $ -13.15M | $ -11.25M |
| Investing Cash Flow | $ -2.52M | $ 259.00K | $ 9.89M | $ -1.24M | $ -3.08M |
| Financing Cash Flow | $ -431.00K | $ -368.00K | $ -131.00K | $ 7.84M | $ -62.00K |
Currency in EUR
